Research Paper Volume 12, Issue 10 pp 9014—9030
miR-125a-5p inhibits glycolysis by targeting hexokinase-II to improve pulmonary arterial hypertension
Figure 5. Effect of miR-125a-5p on PASMCS proliferation. Cell proliferation levels were determined by CCK-8 kit (A) and proliferating cell nuclear antigen (PCNA) (B). Glucose consumption (C) and lactic acid content (D) were measured by assay kits. (*P<0.05, compared with control group, #P<0.05, compared with PH group).